1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Macular Degeneration Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Dry Age-related Macular Degeneration
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Wet Age-related Macular Degeneration
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Stage of Disease
7.1 Early Stage
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Intermediate Stage
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Late Stage
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Intravenous Route
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Intravitreal Route
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgical Center
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Aerie Pharmaceuticals Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.2 Bausch Health Companies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 F. Hoffmann-La Roche Ltd
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.5 Iveric Bio Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.6 Novartis AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7 Panoptica
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Pfizer Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Phio Pharmaceuticals
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.10 Regeneron Pharmaceuticals Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Regenxbio Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Santen Pharmaceutical Co. Ltd.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2023
Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2023
Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2023
Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2023
Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2023
Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2023
Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million US$), 2024-2032
Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
Table 8: Global: Macular Degeneration Treatment Market: Key Players